Only 26.4% of financial institutions express confidence in their AI compliance readiness, according to a Wolters Kluwer Q1 2026 survey1Wolters Kluwer Q1 2026 survey-and that figure faces immediate pressure. A wave of regulatory activity in early 2026 is pushing US financial services and healthcare toward a common expectation: organizations must know precisely where their AI training data came from, how it was transformed, and who is accountable when models fail.
The convergence is not accidental. Federal agencies are responding to years of fragmented, sector-specific AI governance. The emerging consensus centers on data provenance-the documented lineage of data as it moves from source through transformation to model output-as the foundation of trustworthy AI.
The Regulatory Catalyst: Two Sectors, One Direction
Banking: SR 26-2 Replaces SR 11-7
The most concrete signal came in April 2026. The Federal Reserve, FDIC, and OCC rescinded SR 11-7, OCC 2011-12, FIL-22-2017, and related BSA/AML issuances, replacing them with a more explicitly risk-based, principles-driven framework for model risk management. The new guidance, SR 26-2, marks the first major revision to bank model risk management standards in 15 years.
The operational implications are significant. The biggest change: annual revalidation is out, and risk-based oversight tied to model materiality is in. SR 26-2 reframes validation frequency as a function of materiality, change velocity, and data availability, with explicit triggers for re-review.
Critically, SR 26-2 states that "generative AI and agentic AI models are novel and rapidly evolving" and fall outside its scope. However, out of SR 26-2 scope does not mean out of governance scope; institutions still need a parallel framework to govern generative and agentic AI deployments.
The data lineage requirement is embedded in the revised framework's documentation expectations. The 2026 guidance requires banks to "shift left," moving risk controls to the very start of the model lifecycle. That shift demands complete audit trails-including training data provenance-generated during normal model development, not retroactively assembled for examiner review.
Healthcare: FDA, ONC, and the HIPAA Security Rule NPRM
Healthcare AI regulation is advancing along a parallel trajectory. The FDA now treats "Software as a Medical Device" (SaMD) as its own category. In 2025, the agency issued draft guidance for AI-enabled devices focused on documentation, transparency, bias prevention, and post-market monitoring. Rather than a one-time approval, the FDA's "total product lifecycle" approach recognizes that algorithms change and require continuous oversight.
On data provenance specifically, regulators want to trace the origin of training data-to know how it was labeled, validated, and updated, and to ensure it represents the full range of patients it is meant to serve.
The Office of the National Coordinator for Health IT (ONC) is reinforcing this from the interoperability side. ONC is no longer nudging vendors toward interoperability-it is demanding it. By 2026 and beyond, certified systems must prove they can safely integrate AI, disclose algorithmic risks, and deliver seamless FHIR/SMART-based data exchange. In practice, EHR vendors are being held accountable not just for building features but for how those features perform in production. Transparent reporting, continuous interoperability testing, and error-proof AI deployment have become non-negotiable requirements.
The Federal Coordination Layer: White House and NIST
Both sectors operate within a broader federal push for uniformity. The White House released a National Policy Framework for Artificial Intelligence on March 20, 2026, outlining legislative recommendations to guide Congress as it considers federal AI legislation. Across its provisions, the Framework consistently emphasizes national uniformity, reliance on existing legal and regulatory structures, and avoidance of prescriptive or open-ended approaches that could introduce compliance burdens without clear benefit.
For institutions navigating inconsistent state-level requirements, a uniform standard could reduce the complexity of complying with a patchwork of state AI laws. Near-term uncertainty is likely, however, as Commerce completes its evaluation, the FCC and FTC act, and DOJ initiates litigation.
NIST is providing the technical standards backbone. In January and February 2026, the National Institute of Standards and Technology, through its Center for AI Standards and Innovation (CAISI), launched an AI Agent Standards Initiative to support interoperable and secure AI agent systems, issued a Request for Information on securing AI agent systems, and announced virtual listening sessions to identify barriers to AI adoption, including in the financial sector. The sessions are designed to collect sector-specific feedback from financial services, healthcare, and education.
The March 2025 NIST AI RMF update emphasizes model provenance, data integrity, and third-party model assessment, recognizing that most organizations rely on external or open-source AI components.
Sector-by-Sector Comparison
The table below maps key regulatory dimensions across both sectors, highlighting where requirements converge and where sector-specific obligations remain distinct.
{{component:comparison-placeholder}}
Implications for Vendor Interoperability and Third-Party Risk
For technology vendors, the regulatory trajectory creates both obligation and opportunity. Under SR 26-2, outsourced models do not remove accountability. If a vendor provides a credit scoring or stress testing model, the regulated institution remains responsible under model risk management guidance. Independent validation and performance monitoring still apply.
In healthcare, the vendor liability landscape is equally demanding. AI vendors are typically liable for defects in the system itself-software bugs, safety flaws, or misrepresentations about capabilities. Vendors cannot contract away responsibility for personal injury, and non-compliance with FDA or HIPAA rules strengthens the case against them.
Healthcare, financial services, and education are all regulated industries where AI agent deployments must contend with existing compliance frameworks-HIPAA, Gramm-Leach-Bliley, FERPA-that were not written with autonomous AI systems in mind. The barriers practitioners identify will likely surface specific gaps between existing regulatory requirements and the operational realities of deploying agents that can read, modify, and transmit sensitive data autonomously.
Vendors that demonstrate standardized provenance metadata, interoperable audit trail formats, and documented data lineage will hold a procurement advantage as institutions update contracts to reflect new regulatory expectations. While NIST and CAISI initiatives are not binding regulations, their frameworks frequently influence supervisory expectations, procurement standards, and industry best practices, especially in regulated sectors such as financial services.
This dynamic is explored in detail in an earlier analysis of unified AI governance for bank workflow agents, which examines the interoperability standards and vendor risk guidelines taking shape across multi-vendor banking environments.
The Data Governance Gap Institutions Must Close
Despite the regulatory momentum, readiness gaps remain significant across both sectors. AI and machine learning models now account for roughly half of the average large bank's model inventory, yet only 26.4% of financial institutions express confidence in their AI compliance readiness as of Q1 2026. Meanwhile, 58.8% of banks cite clearer regulatory guidance as the single biggest barrier to advancing their model risk management and AI strategy.
In healthcare, data transformation deserves more executive attention than it typically receives. Many AI programs are delayed or weakened not by model selection but by poor data readiness. If the underlying data is fragmented, inconsistently labeled, poorly governed, or operationally misunderstood, AI scales confusion faster than it scales value.
The data governance foundations for autonomous AI explored in a related analysis underscore how cross-sector institutions are approaching quality, privacy, and risk in tandem.
Organizations must establish policies for sourcing data legally, ensuring consent where applicable, and documenting data provenance. This includes verifying the accuracy, completeness, and diversity of AI training data to prevent biased outcomes. Strong AI data management involves versioning training datasets, labeling data with appropriate metadata, and maintaining logs of data access and transformations in AI workflows.
Near-Term Priorities: What Institutions Should Do Now
The interactive readiness checker below assesses an organization's current AI data provenance posture across lineage, governance, vendor risk, and regulatory alignment.
{{widget:readiness-checker-placeholder}}
For institutions building or accelerating compliance programs, the following actions are most time-sensitive:
{{component:steps-placeholder}}
Conclusion
The move toward unified AI data provenance standards in banking and healthcare represents a structural shift in how regulators expect institutions to govern AI-from output-level controls to lifecycle-level accountability. With SR 26-2 now in effect, the White House AI Policy Framework setting a federal direction, and NIST developing cross-sector agent standards, the question for CIOs, CTOs, and compliance leaders is no longer whether data lineage requirements will arrive, but whether their governance infrastructure will be ready when they do.
Technology vendors that embed provenance transparency into their core architecture-rather than treating it as a compliance add-on-are best positioned to meet the procurement expectations of regulated institutions in both sectors.
